Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms

被引:10
|
作者
Shepard, C. Joy [1 ,2 ]
Cline, Sara G. [1 ]
Hinds, David [3 ,4 ]
Jahanbakhsh, Seyedehameneh [4 ]
Prokop, Jeremy W. [4 ,5 ]
机构
[1] Athens State Univ, Dept Biol, Athens, AL USA
[2] Univ Alabama Birmingham, Grad Biomed Sci, Birmingham, AL USA
[3] HudsonAlpha Inst Biotechnol, Huntsville, AL USA
[4] Michigan State Univ, Dept Pediat & Human Dev, Coll Human Med, Grand Rapids, MI USA
[5] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
基金
美国国家卫生研究院;
关键词
data integration; eQTL; GWAS; multiple sclerosis; omics; GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RISK; SUSCEPTIBILITY; METAANALYSIS; RGS14; GFI1; AFF3; IDENTIFICATION; CONCORDANCE;
D O I
10.1152/physiolgenomics.00120.2018
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Genetics of multiple sclerosis (MS) are highly polygenic with few insights into mechanistic associations with pathology. In this study, we assessed MS genetics through linkage disequilibrium and missense variant interpretation to yield a MS gene network. This network of 96 genes was taken through pathway analysis, tissue expression profiles, single cell expression segregation, expression quantitative trait loci (eQTLs), genome annotations, transcription factor (TF) binding profiles, structural genome looping, and overlap with additional associated genetic traits. This work revealed immune system dysfunction, nerve cell myelination, energetic control, transcriptional regulation, and variants that overlap multiple autoimmune disorders. Tissue-specific expression and eQTLs of MS genes implicate multiple immune cell types including macrophages, neutrophils, and T cells, while the genes in neural cell types enrich for oligodendrocyte and myelin sheath biology. There are eQTLs in linkage with lead MS variants in 25 genes including the multitissue eQTL, rs9271640, for HLA-DRB1/DRB5. Using multiple functional genomic databases, we identified noncoding variants that disrupt TF binding for GABPA, CTCF, EGR1, YY1, SPI1, CLOCK, ARNTL, BACH1, and GFI1. Overall, this paper suggests multiple genetic mechanisms for MS associated variants while highlighting the importance of a systems biology and network approach when elucidating intersections of the immune and nervous system.
引用
收藏
页码:562 / 577
页数:16
相关论文
共 50 条
  • [31] Fibrinogen: A potential biomarker for predicting disease severity in multiple sclerosis.
    Ahmad, Usman
    Frederiksen, Jette Lautrup
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [32] A disease- specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis
    Mechelli, Rosella
    Umeton, Renato
    Bellucci, Gianmarco
    Bigi, Rachele
    Rinaldi, Virginia
    Angelini, Daniela F.
    Guerrera, Gisella
    Pignalosa, Francesca C.
    Ilari, Sara
    Patrone, Marco
    Srinivasan, Sundararajan
    Cerono, Gabriel
    Romano, Silvia
    Buscarinu, Maria C.
    Martire, Serena
    Malucchi, Simona
    Landi, Doriana
    Lorefice, Lorena
    Steinman, Lawrence
    Umeton, Raffaella Pizzolato
    Anastasiadou, Eleni
    Trivedi, Pankaj
    Fornasiero, Arianna
    Ferraldeschi, Michela
    Di Sapio, Alessia
    Marfia, Gerolama
    Cocco, Eleonora
    Centonze, Diego
    Uccelli, Antonio
    Di Silvestre, Dario
    Mauri, Pierluigi
    de Candia, Paola
    D'Alfonso, Sandra
    Battistini, Luca
    Farina, Cinthia
    Magliozzi, Roberta
    Reynolds, Richard
    Baranzini, Sergio E.
    Matarese, Giuseppe
    Salvetti, Marco
    Ristori, Giovanni
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2025, 122 (14)
  • [33] Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon
    Marta, Monica
    Giovannoni, Gavin
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (05) : 610 - 623
  • [34] An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease
    Eslahi, Maedeh
    Nematbakhsh, Negin
    Dastmalchi, Narges
    Teimourian, Shahram
    Safaralizadeh, Reza
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (03) : 381 - 393
  • [35] SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
    MacDougall, Madison
    Sleiman, Jad El-Hajj
    Beauchemin, Philippe
    Rangachari, Manu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] Emerging T cell immunoregulatory mechanisms in multiple sclerosis and Alzheimer's disease
    Hawiger, Daniel
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [37] Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis
    Bogosian, Angeliki
    Hughes, Alicia
    Norton, Sam
    Silber, Eli
    Moss-Morris, Rona
    BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2016, 21 (04) : 859 - 880
  • [38] Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease
    Arezoo Hosseini
    Zohreh Babaloo
    Tohid Gharibi
    Navid Shomali
    Faroogh Marofi
    Vida Hashemi
    Hormoz Ayromlou
    Milad Asadi
    Shima Rahmani
    Saeed Noorolyai
    Dariush Shanehbandi
    Behzad Baradaran
    BMC Research Notes, 13
  • [39] The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics
    Schoonheim, Menno M.
    Broeders, Tommy A. A.
    Geurts, Jeroen J. G.
    NEUROIMAGE-CLINICAL, 2022, 35
  • [40] Selective amygdalo-hippocampectomy as a potential trigger for disease progression in multiple sclerosis
    Ehling, Rainer
    Dobesberger, Judith
    Unterberger, Iris
    Benke, Thomas
    Gotwald, Thaddaeus
    Ortler, Martin
    Berger, Thomas
    Trinka, Eugen
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (02) : 136 - 138